Rock Springs Capital Management’s Health Catalyst HCAT Stock Holding History

Rock Springs Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-307,500	Closed	-$3.11M	–	110
2023 Q3	$3.11M	Sell	307,500 -622,400	-67%	-$7.43M	0.08%	91
2023 Q2	$11.6M	Hold	929,900	–	–	0.28%	73
2023 Q1	$10.9M	Hold	929,900	–	–	0.26%	76
2022 Q4	$9.88M	Buy	929,900 +49,900	+6%	+$482K	0.24%	73
2022 Q3	$8.54M	Sell	880,000 -65,400	-7%	-$866K	0.22%	84
2022 Q2	$13.7M	Buy	945,400 +31,900	+3%	+$544K	0.4%	65
2022 Q1	$23.9M	Buy	913,500 +63,300	+7%	+$1.8M	0.6%	56
2021 Q4	$33.7M	Buy	850,200 +200	+0%	+$9.12K	0.78%	42
2021 Q3	$42.5M	Buy	850,000 +65,000	+8%	+$3.55M	0.89%	39
2021 Q2	$43.6M	Hold	785,000	–	–	0.86%	37
2021 Q1	$36.7M	Hold	785,000	–	–	0.8%	43
2020 Q4	$34.2M	Buy	785,000 +82,000	+12%	+$3.02M	0.72%	48
2020 Q3	$25.7M	Buy	703,000 +278,000	+65%	+$9.44M	0.65%	50
2020 Q2	$12.4M	Hold	425,000	–	–	0.34%	94
2020 Q1	$11.1M	Buy	425,000 +265,000	+166%	+$8.1M	0.46%	70
2019 Q4	$5.55M	Buy	160,000 +35,000	+28%	+$1.16M	0.18%	105
2019 Q3	$3.96M	Buy	+125,000	New	+$4.92M	0.16%	114

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rock Springs Capital Management's HCAT Position: Q4 2023 in Review

Rock Springs Capital Management sold out of Health Catalyst (HCAT) in Q4 2023, closing a stake of 307,500 shares — an estimated $3.11M sold.

Rock Springs Capital Management first reported a position in HCAT in Q3 2019 and held it in 17 quarters. The position peaked at $43.6M in Q2 2021. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2023.

Rock Springs Capital Management reported no remaining Health Catalyst position as of Q4 2023 after selling out during the quarter.
Rock Springs Capital Management sold 307,500 Health Catalyst shares in Q4 2023, an estimated $3.11M.
Rock Springs Capital Management first reported a position in Health Catalyst in Q3 2019 and held it in 17 quarters.
Rock Springs Capital Management's Health Catalyst position peaked at $43.6M in Q2 2021.
167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2023.

Based on Rock Springs Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.